Business
TLX101 for Glioblastoma Therapy - Clinical Trial Update
TLX101 for Glioblastoma Therapy - Clinical Trial Update
About this update from Telix Pharmaceuticals Limited
[{"type":"text","content":"Telix Pharmaceuticals Ltd has released a press release. View Attachment","length":248,"tagName":"div"}]